- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03907696
Reducing Stigma Towards Psychiatry Among Medical Students
Reducing Stigma Towards Psychiatry Among Medical Students: a Multicenter Controlled Trial
This study examines the effect of including a novel Anti-stigma Intervention Curriculum (ASIC) during a clinical rotation in psychiatry during medical school. It addresses stigma in medical students' perceptions of psychiatric patients, psychiatric illnesses and treatments, and the knowledge base of psychiatry in clinical practice.
Medical students from eight hospitals were divided into intervention (one hospital, n=57) and control (seven hospitals, n=163) arms at the beginning of a 6-week psychiatry rotation throughout one academic year (2017/18). The students completed the Attitudes to Psychiatry scale (ATP-30) and the Attitudes toward Mental Illness scale (AMI) at rotation onset and conclusion. The ASIC was designed to target prejudices and stigma by direct informal encounters with people with severe mental illness (SMI) during periods of remission and recovery. Supervised small group discussions followed those encounters in order to facilitate processing of thoughts and emotions that ensued, and to discuss salient topics, including psychiatric care, evidence-based medicine in psychiatry, and the neuroscientific underpinnings of clinical psychiatry.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Design and participants- This study used a controlled trial design. The study population consisted of medical students during their six-week psychiatry clerkship. The study was conducted between November 2017 and July 2018 in eight academic hospitals in central Israel. There were 16 groups of students.
The intervention arm included 3 groups of students (n=57) at a single general hospital, and the control group was comprised of 13 groups of students (n=163) from six psychiatric hospitals (n=139) and one general hospital (n=24). All students were informed that the purpose of the study was to explore their attitudes about people with mental illness and about psychiatry in general at the beginning (baseline) and at the end (endpoint) of their rotation. The participants were assured that their responses would remain confidential, and that they would not influence their rotation grade.
Procedure - The intervention and control groups received the same lecture and practical training components. Topics covered in the lectures included psychopathology, psychopharmacological treatment, psychotherapy, and forensic psychiatry. Practical training included participation in inpatient rounds, visits at outpatient clinics and consultation-liaison services, and seminars consisting of patient interviews and discussions of clinical cases. All students were placed in a psychiatric ward, under the supervision and responsibility of psychiatric residents and senior psychiatrists. Each ward had a range of 4 to 7 students assigned to it. During the rotation, students assumed supervised clinical responsibility for at least one clinical case. Although all students were exposed to a variety of patients in different clinical scenarios, they were exposed mostly to acutely ill inpatients.
Study intervention The Anti-Stigma Interventions Curriculum (ASIC) component that was added to the intervention group was designed to target stigma towards psychiatric patients, psychiatric treatment, and the knowledge base of clinical practice in psychiatry. A first part, aimed at reducing stigma towards psychiatric patients, consisted of two forms of direct encounters with individuals with serious mental illness (SMI) in recovery or rehabilitation: 1) A two-hour panel of three people who shared their personal stories as consumers of mental health services, followed by an open discussion with the students; and 2) A visit to a rehabilitation center, which included direct contact with the consumers. The emphasis in both of those encounters was on exposing students to the competence and strengths of the individuals, rather than to the symptoms and signs of their underlying illnesses. The second part, which was designed to target stigma towards psychiatric treatment and the knowledge base of clinical practice in psychiatry, included small group discussions (20 minutes each) on the efficacy of different treatments, the clinical utility of admission to inpatient wards, evidence-based medicine in psychiatry, and the biological pathways underpinning psychiatric disorders.
The study was conducted after receiving Helsinki ethics committee approval for a multicenter study from the University of Tel Aviv Institutional Review Board. Because the ethics committee approval was contingent on personal information being de-identified, the investigators only used aggregate, unpaired pre- and post-rotation data.
Study evaluations Participants completed one socio-demographic and two self-report questionnaires, the Attitudes to Psychiatry (ATP-30)22, and the Attitudes to Mental Illness (AMI)7, which were administrated through a secured online server (SurveyMonkey®). The ATP-30 consists of 30 items, and it measures medical students' attitudes towards eight different attitudinal domains: 1) Psychiatric patients; 2) Psychiatric illness; 3) Psychiatric treatment; 4) Psychiatric institutions; 5) Psychiatric knowledge base in clinical practice; 6) Psychiatric education; 7) Psychiatry as a career choice; and 8) Psychiatrists. The AMI consists of 20 items, and it measures medical students' attitudes to mental illnesses and, more specifically, towards their causes, treatments, and impact on individuals and society. Each item in both questionnaires is rated on a 5-point Likert scale ranging from strongly agree to strongly disagree. Some items are negatively phrased in order to minimize the likelihood of social desirability bias, and higher composite scores indicate more favorable attitudes (less stigma) toward mental illness. Both ATP-30 and AMI have been shown to have good psychometric properties, and both have been translated into many languages and used in many countries worldwide.7,22
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Tel Aviv, Israel, 6432633
- Doron Amsalem
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All medical students in psychiatric rotation during the academic year of 2017-2018 affiliated to Tel Aviv University
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Intervention
The intervention arm participate in an educational program that aimed at reducing stigma
|
educational curriculum aimed at reducing stigma
|
No Intervention: control
regular curriculum with no addition educational contents
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Attitude toward psychiatry (ATP) scale
Time Frame: 6 weeks (psychiatric rotation)
|
scale that measure stigma among medical students.
30 statements, scale of 1 (strongly disagree) to 5 (strongly agree).
Minimum score: 30; maximum score: 150; Higher scores indicate less stigma.
|
6 weeks (psychiatric rotation)
|
Attitude toward mental illness (AMI) scale
Time Frame: 6 weeks (psychiatric rotation)
|
scale that measure stigma among medical students.
30 statements, scale of 1 (strongly disagree) to 5 (strongly agree).
Minimum score: 20; maximum score: 100.
Higher scores indicate less stigma.
|
6 weeks (psychiatric rotation)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Doron Amsalem, MD, Sheba Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 4716-17-SMC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stigma, Social
-
University of TorontoCompletedSocial StigmaLesotho, Swaziland
-
University of ChicagoPlanned Parenthood Federation of AmericaCompleted
-
Indiana UniversityCompletedStigma, Social | TransgenderismUnited States
-
Karolinska InstitutetUniversity of Nairobi; Moi UniversityCompletedPregnancy | Contraception | Social StigmaKenya
-
King's College LondonGroundswell; Lambeth Service Users Council; Museum of Homelessness; Inclusive InsightNot yet recruiting
-
Centre d'Higiene Mental Les CortsCompletedMental Health | Stigma, SocialSpain
-
RANDNational Alliance on Mental Illness CaliforniaRecruitingStigma, Social | Help-Seeking BehaviorUnited States
-
University College DublinCompletedStigma, Social | Well-Being | ShameIreland
-
Emory UniversityNational Institute of Nursing Research (NINR)Not yet recruitingPsychological Distress | Stigma, Social
-
The Hong Kong Polytechnic UniversityRecruiting
Clinical Trials on Anti-stigma interventions curriculum
-
University of California, RiversideNational Institute of Mental Health (NIMH)CompletedMental Illness | Stigma, Social
-
University of ConnecticutNational Institute of Mental Health (NIMH)Completed
-
RTI InternationalSetshaba Research CentreCompletedHIV PreventionSouth Africa
-
RTI InternationalNational Institute of Mental Health (NIMH); SisterLove, Inc.; Positive Impact...Not yet recruitingSubstance Use Disorder | Mental Health Disorder | Implementation Science | StigmatizationUnited States
-
University of MichiganBeira Operational Research CenterCompletedHuman Immunodeficiency Virus (HIV) InfectionMozambique
-
KU LeuvenBelgian Red Cross; University Ghent; Laerdal MedicalCompletedAcute Myocardial InfarctionBelgium
-
National Health Promotion Associates, Inc.UnknownSubstance Use | Substance Abuse | Cyberbullying | BullyingUnited States
-
University of PennsylvaniaCompleted
-
Harvard UniversityNot yet recruitingMental Health Issue | Stigma, SocialUnited States
-
Novartis PharmaceuticalsGenentech, Inc.Completed